CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K/A Event Exhibits
- 4 Gift Director gave 20,445 shares (gift)
- 4 Option exercise Director acquired 20,445 shares (option exercise)
- S-3ASR Offering Registration Statement
- 4 Gift Executive Vice President gave 80,000 shares (gift)
- 4 Gift Executive Vice President gave 152,426 shares (gift)
- 4 Open-market sale Director sold 50,000 shares at $17.64 ($882,000)
- 4 Open-market sale Executive Vice President sold 146,403 shares at $17.51 ($2,563,517)
- 4 Open-market sale EVP, Chief Legal Officer sold 216,613 shares at an average $17.41 ($3,771,050)
- 4 Option exercise Director acquired 168,573 shares (option exercise)
- 144 Insider Sale of Securities
- 4 Grant or award 10% owner acquired 12,763,469 shares (grant or award)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Co-CEO acquired 6,381,734 shares (grant or award)
- 4 Grant or award Director acquired 283,632 shares (grant or award)
- 4 Grant or award President & Co-CEO acquired 6,381,734 shares (grant or award)
Page 1 of 35 · 695 filings